Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-12

Clinical Trial Update: Furazolidone Quadruple Regimen Eradicate H. Pylori Infection [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on a furazolidone-based quadruple regimen for Helicobacter pylori infection, with completed Phase 1 and Phase 2 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Furazolidone (furazolidone)

Snippet

Sponsor: Liaocheng People's Hospital | Conditions: Helicobacter Pylori Infection, Eradication | Phase 1, Phase 2 | Status: COMPLETED